- Question from Lise: Please comment on the results of the most recent study of Zometa and recurrence and how the results differ from previous studies of the same. Thank you!
- Answers - Eric Winer, M.D. The results of the most recent study indicate that Zometa does not prevent a recurrence of breast cancer. There is one large study that was reported approximately 2 years ago that said that Zometa might prevent recurrences in young women who are placed on medications that put them into menopause. The most recent study does not appear to support that finding, and as a result, doctors should be very thoughtful and very selective about the use of Zometa to prevent recurrence. Many doctors will decide not to use it whatsoever in this situation, which is certainly reasonable. All drugs have side effects, and drugs like Zometa, while reasonably well tolerated, can in and of themselves cause problems.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.